Weight-loss drugs could stop hormone replacement therapy from working and increase the associated risks, guidance has warned.

Omada Health shares jumped after the company made its public-market debut, propelled by Americans’ renewed focus on how ...

Omada is trading publicly after 14 years of providing support to patients with weight-related chronic illnesses. Leadership sees the current moment as the perfect time for an IPO, as GLP-1 drugs such ...

This two-bedroom end-of-terrace house in Clydebank is listed for £150,000. With a modern interior, spacious garden, and ...

I've been a Novo Nordisk bull for quite some time now, and I wouldn't be as spooked by the situation. Here's why. Novo Nordisk got a two-year-plus head start in the white-hot obesity drugs market, ...

U.K. regulators issued guidance on Thursday, warning weight loss and diabetes medications may weaken the effectiveness of ...

So, what's the tea on microdosing? It's pretty much what it sounds like — taking smaller doses than the usual prescribed ...

Health experts are raising concerns for women using popular weight loss medications, particularly GLP-1s like Wegovy, ...

Ozempic, which was introduced into the UK in January 2019, having previously been approved in the US in 2017, is an ...

Also: A Medicare crisis and doctors’ concerns with Kennedy’s new coronavirus vaccine policy.